Anti-Human GM-CSF Reference Antibody (Gimsilumab, RUO) (HY213046)

Datasheet Share product Copy info

Price(USD): $

Spec:

100ug
1mg

Number:

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HY213046
Description	Research Grade Gimsilumab (HY213046) is a human monoclonal antibody detecting Granulocyte-macrophage colony-stimulating factor in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human. Highlights ●Multi-Application — Validated across multiple applications.
Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG1-kappa
Expression system	Mammalian Cells
Species	Human
Clonality	Monoclonal
Target	Granulocyte-macrophage colony-stimulating factor, Sargramostim, GMCSF, CSF, Colony-stimulating factor, CSF2, GM-CSF, Molgramostin
Endotoxin level	Please contact with the lab for this information.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	P04141
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	MORAb-022, 1648796-29-5
Background	Granulocyte-macrophage colony-stimulating factor (Granulocyte-macrophage colony-stimulating factor,Sargramostim,GMCSF,CSF,Colony-stimulating factor,CSF2,GM-CSF,Molgramostin) is a ~16 kDa protein. Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.
Note	For research use only. Not suitable for clinical or therapeutic use.